US 10448637
Inhibitors of GRB2-associated binding protein 1 (GAB1) and methods of treating cancer using the same
granted A61KA61K31/00A61K31/10
Quick answer
US patent 10448637 (Inhibitors of GRB2-associated binding protein 1 (GAB1) and methods of treating cancer using the same) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arizona Board of Regents on Behalf of the University of Arizona
- Grant date
- Tue Oct 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/00, A61K31/10